Global Soft Tissue Allografts Market to Reach $7.1 Billion by 2030
The global market for Soft Tissue Allografts estimated at US$4.8 Billion in the year 2022, is projected to reach a revised size of US$7.1 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2022-2030. Orthopedic, one of the segments analyzed in the report, is projected to record 4.9% CAGR and reach US$2.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Dentistry segment is readjusted to a revised 5.5% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 4.5% CAGR
The Soft Tissue Allografts market in the U.S. is estimated at US$1.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 4.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.Select Competitors (Total 41 Featured) -
- Alliqua BioMedical, Inc.
- Arthrex, Inc.
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- ConMed Corporation
- Globus Medical, Inc.
- Integra Lifesciences Corporation
- Lattice Biologics Ltd.
- Organogenesis, Inc.
- Osiris Therapeutics, Inc.
- Straumann
- Xtant Medical
- Zimmer Biomet Holdings, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alliqua BioMedical, Inc.
- Arthrex, Inc.
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- ConMed Corporation
- Globus Medical, Inc.
- Integra Lifesciences Corporation
- Lattice Biologics Ltd.
- Organogenesis, Inc.
- Osiris Therapeutics, Inc.
- Straumann
- Xtant Medical
- Zimmer Biomet Holdings, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 4.8 Billion |
| Forecasted Market Value ( USD | $ 7.1 Billion |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Global |
